Cyclarity

Elastrin

This biotechnology company develops nanoparticle therapies targeting damaged elastin to reverse tissue calcification for patients with cardiovascular and age-related diseases.

Nanophagix

This biotechnology firm develops chemical conjugates and nanoparticle drug delivery platforms for pharmaceutical companies to treat atherosclerosis and other cardiovascular conditions.

AtheroMed

This company develops a catheter system that removes plaque from arteries for physicians treating patients with peripheral artery disease.

BioAge Labs

This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.

Cleara Biotech

The company develops peptide-based therapies that target and eliminate senescent cells to treat patients with late-stage cancers and age-related chronic diseases.

ProCorde AG

This cardiovascular-focused company develops therapies for thrombosis and vascular dysfunction to treat patients suffering from coronary artery disease and other cardiovascular pathologies.

Cardiatec

This company develops an artificial intelligence platform to identify novel drug targets and therapeutics for cardiovascular diseases for the pharmaceutical and healthcare industries.

Aortyx

This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.